BEGIN:VCALENDAR
VERSION:2.0
PRODID:-//AssetMemo//Readout calendar//EN
CALSCALE:GREGORIAN
METHOD:PUBLISH
X-WR-CALNAME:ION775 readouts · AssetMemo
X-WR-CALDESC:Upcoming readouts of ION775\, from ClinicalTrials.gov estimate
 s.
REFRESH-INTERVAL;VALUE=DURATION:PT12H
X-PUBLISHED-TTL:PT12H
BEGIN:VEVENT
UID:NCT07604974-1085@assetmemo.bio
DTSTAMP:20261121T005556Z
DTSTART;VALUE=DATE:20270930
DTEND;VALUE=DATE:20271001
SUMMARY:ION775: Phase 2 readout est. (NCT07604974)
DESCRIPTION:ION775\, phase 2\, Severe Hypertriglyceridemia.\nStudy: A Study
  to Assess the Safety\, Tolerability and Efficacy of ION775\nEstimated pri
 mary completion: September 2027. This is a ClinicalTrials.gov estimate\, n
 ot a confirmed readout date\, and it can move.\nDrug page: https://assetme
 mo.bio/drug/ion775#upcoming-events\nRegistry record: https://clinicaltrial
 s.gov/study/NCT07604974
URL:https://assetmemo.bio/drug/ion775#upcoming-events
TRANSP:TRANSPARENT
END:VEVENT
END:VCALENDAR
